PQA

NOVEMBER 12, 2024

Focus first on access to specialty pharmacies and then on ongoing engagement. Specialty pharmacy is a high-touch model, but even it needs to go above and beyond for those with rare disease. Save the date to join us at the 2025 PQA Annual Meeting, May 19-21 in Tampa! Thank you to our sponsors!

Specialty Pharmacies 52

Specialty Pharmacies Insurance FDA 52

PQA

SEPTEMBER 30, 2024

As we continue progress towards completion of our strategic plan, Blueprint PQA 2025, our team has been hard at work alongside our valued members to deliver meaningful improvements and drive positive change in quality medication use. Successfully piloting pharmacy measure concepts focused on blood pressure and A1c improvement and control.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Communication 52

Omnicell

JANUARY 10, 2023

Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.

Specialty Pharmacies 52

Specialty Pharmacies Omnicell Hospitals Communication 52

PQA

NOVEMBER 3, 2023

PQA is now accepting applications for our student and professional programs for 2024-2025. Specialty medications require a lot of resources to manage, and so specialty pharmacies want to be sure their patients can access and use their medications.

Specialty Pharmacies 52

Specialty Pharmacies 52

PQA

APRIL 5, 2024

We also highlight two important, just released CMS policies and our members' perspectives pharmacy deserts and specialty pharmacy. Yesterday, April 4, CMS issued the Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F).

Specialty Pharmacies 40

Specialty Pharmacies Community Pharmacies 40

PQA

OCTOBER 16, 2024

PQA offers a competitive Advanced Pharmacy Practice Experiential (APPE) Rotation for pharmacy students, which provides experiential learning opportunities in non-profit association management, medication use quality education, communications, research and performance measurement. You can apply here.

Specialty Pharmacies 52

Specialty Pharmacies Patient Care Communication Pharmaceutical Companies 52

PQA

JANUARY 31, 2025

Quality Medication Use in Rare Disease Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. Read more inChain Drug Review. The registration link is in theMember Resources Library.

Specialty Pharmacies 52

Specialty Pharmacies Patient Care Community Pharmacies 52

PQA

NOVEMBER 14, 2024

Cost highlighted progress towards completion of PQA’s strategic plan, Blueprint PQA 2025. Standardized pharmacy measures address that need and can support pharmacies, payers, manufacturers, and other stakeholders when considering network, value-based care, and quality improvement opportunities.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

PQA

OCTOBER 18, 2024

Exploring Quality Medication Use in Rare Disease PQA Convenes: Quality Medication Use in Rare Disease will feature the perspectives of patients, caregivers, patient advocates, specialty pharmacies, biopharmaceutical industry representatives, and public and private payers on quality in rare disease. Learn more.

Specialty Pharmacies 52

Specialty Pharmacies Patient Care 52

PQA

OCTOBER 4, 2024

In addition to the immunization pilots, summit panels and discussions will also address work on blood pressure and hemoglobin A1C improvement and control, and specialty pharmacy turnaround time. Save the date to join us at the 2025 PQA Annual Meeting, May 19-21, at the JW Marriott Tampa Water Street in Tampa, Fla. Learn more.

Immunization 52

Immunization Specialty Pharmacies 52

PQA

JANUARY 17, 2023

It’s a new year and there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care. With our strategic plan, Blueprint PQA 2025, PQA has sharpened its focus around several priority areas and will continue to deepen our work in these areas in the coming years.

Specialty Pharmacies 40

Specialty Pharmacies 40

PQA

SEPTEMBER 25, 2023

We continue to play a central role in driving meaningful improvements and positive changes related to medication safety, adherence and appropriate use.The 2023 PQA Annual Report documents our progress towards Blueprint PQA 2025. There are still numerous opportunities to be involved with PQA and impact quality medication use in 2023.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

PQA

APRIL 16, 2025

The upcoming 2025 PQA Annual Meetings poster session will showcase 19 quality improvement and research projects. This session offers authors a platform to exhibit their work and enables attendees to engage in insightful discussions about healthcare quality.

Specialty Pharmacies 40

Specialty Pharmacies Nursing Homes Community Pharmacies Hospitals 40

PQA

FEBRUARY 14, 2025

Transforming Pharmacy PracticeXiFinhaspreviewedfindings from its 2025 Pharmacy Transformation Outlook Survey, which highlights the growing role of pharmacists and the increasing interest in achieving operational efficiency through new technology and expanding pharmacy offerings via value-based care and specialty pharmacy.

Specialty Pharmacies 52

Specialty Pharmacies Patient Care 52

PQA

JANUARY 12, 2024

Looking ahead, we are excited to announce dates for the 2024 Leadership Summit, as well as the 2025 and 2026 Annual Meetings. Our 2025 Annual Meeting will be in Tampa, Fla., We know you have busy schedules and many meetings to attend throughout the year. This will help you plan far in advance, so that you don't miss any PQA events!

Specialty Pharmacies 64

Specialty Pharmacies Vaccines 64

The Checkup by Singlecare

SEPTEMBER 10, 2024

There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. But Stelara is a biologic product , meaning it will have what’s called a biosimilar instead of a generic version. Continue reading to learn more about Stelara and its biosimilars.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

PQA

NOVEMBER 1, 2024

Monitoring Oral Chemotherapy Outcomes A new study by specialty pharmacists from Vanderbilt Specialty Pharmacy detailed that a tailored clinical monitoring schedule focused on oral oncolytics with high rates of adverse events (AEs) slashed treatment interruptions by more than 50% and significantly reduced medication-related hospitalizations.

Specialty Pharmacies 52

Specialty Pharmacies Vaccines Chemotherapy Immunization 52

PQA

FEBRUARY 28, 2025

-- Melanie Lam, PharmD, Executive Fellow Addressing Rare Disease Pharmacy Management Asession hosted byURACat the 2024 NASP Annual Meeting & Expodiscussedthe unique natureand opportunitiesof rare disease pharmacy management, and how different health systems have tackled this specialty.

Insurance Coverage 52

Insurance Coverage Specialty Pharmacies Community Pharmacies Insurance 52